Cancer Immunotherapy May Weaken Bones in Melanoma Survivors
Study examines bone density loss in melanoma patients receiving immune-boosting cancer drugs like nivolumab and pembrolizumab.
51 articles in this topic
Study examines bone density loss in melanoma patients receiving immune-boosting cancer drugs like nivolumab and pembrolizumab.
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
HIIT training studied in 52 men with prostate cancer on active surveillance to evaluate exercise benefits during watchful waiting.
Small study explores cerebrospinal fluid exosomes to better diagnose breast cancer spread to brain and spinal cord.
New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.